Futura Medical (LON:FUM) Shares Down 5.7% – What’s Next?

Futura Medical plc (LON:FUM) shares fell 5.7% during trading on Tuesday . The company traded as low as GBX 0.63 and last traded at GBX 0.63. 1,970,943 shares traded hands during mid-day trading, a decline of 68% from the average session volume of 6,253,206 shares. The stock had previously closed at GBX 0.67.

Futura Medical Stock Down 10.4%

The stock has a market cap of £3.49 million, a PE ratio of -0.22 and a beta of 0.01. The business has a 50 day moving average price of GBX 1.03 and a 200 day moving average price of GBX 1.21.

Futura Medical (LON:FUM) last issued its earnings results on Wednesday, April 29th. The company reported GBX (2.78) EPS for the quarter. Futura Medical had a negative return on equity of 310.00% and a negative net margin of 534.62%.The company had revenue of GBX 170 million during the quarter. On average, research analysts predict that Futura Medical plc will post 2.8486672 earnings per share for the current fiscal year.

Futura Medical Company Profile

Futura Medical plc (AIM: FUM) is the developer of innovative sexual health products, including lead product Eroxon® and products WSD4000 and Eroxon® Intense. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products.

Sexual health issues are prevalent in both men and women. ED impacts 1 in 5 men globally across all adult age brackets, with approximately half of all men over 40 experiencing ED and 25% of all new diagnoses being in men under 40.